Cargando…
Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART
Although HAART suppresses HIV replication, it is often unable to restore immune homeostasis. Consequently, non-AIDS-defining diseases are increasingly seen in treated individuals. This is attributed to persistent virus expression in reservoirs and to cell activation. Of note, in CD4(+) T cells and m...
Ejemplares similares
-
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
por: Ensoli, Fabrizio, et al.
Publicado: (2015) -
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4(+) T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study
por: Bellino, Stefania, et al.
Publicado: (2014) -
Anti-Tat immunity defines CD4(+) T-cell dynamics in people living with HIV on long-term cART.
por: Tripiciano, Antonella, et al.
Publicado: (2021) -
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
por: Sgadari, Cecilia, et al.
Publicado: (2019) -
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
por: Ensoli, Barbara, et al.
Publicado: (2016)